Maxime P. Look - Concepedia

Author

Maxime P. Look

Erasmus MC

Also Known As

J.A. Foekens, Joie Ensor, M LOOK, M Look, M P Look, M. Look, M. P Look, M. P. Look, M.P Look, M.P. Look

162

Publications

13.4K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus MC Cancer Institute Rotterdam University of Applied Sciences Erasmus University Rotterdam Cancer Genomics Centre

About

Maxime P. Look is an author at Erasmus MC specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	43	7.7K
2	Engineering	3	3	4.1K
3	Public Health	3	3	87
4	Health Sciences	1	1	155
5	Biochemistry	1	1	39

Maxime P. Look

100

Publications

12.8K

Citations

H-Index

Page 1

	Year	Citations
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yixin Wang, Jan G.M. Klijn, Yi Zhang, The Lancet Radiation OncologyBreast OncologyOncologyEngineeringDistant Metastasis	2005	2.7K
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yongyu Wang, J.G.M. Klijn, Y ZHANG, The Lancet Radiation OncologyBreast OncologyOncologyEngineeringDistant Metastasis	2005	1.2K
Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy, JNCI Journal of the National Cancer Institute	2002	600
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. John A. Foekens, Harry A. Peters, Maxime P. Look, PubMed Tumor BiologyBreast OncologyOncologyPlasminogen ActivationBreast Cancer Patients	2000	429
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer John A. Foekens, Anieta M. Sieuwerts, Marcel Smid, Proceedings of the National Academy of Sciences	2008	365
Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling Maurice P.H.M. Jansen, John A. Foekens, Iris L. van Staveren, Journal of Clinical Oncology	2005	331
High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. John A. Foekens, Harry A. Peters, Nicolaï Grebenchtchikov, PubMed Breast OncologyImmunologyPathologyTumor BiologyAdvanced Breast Cancer	2001	300
RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Herman Burger, John A. Foekens, Maxime P. Look, PubMed	2003	292
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients John A. Foekens, Maxime P. Look, Joan Bolt‐de Vries, British Journal of Cancer Prognostic BiomarkersBreast OncologyOncologyTumour ExtractsPathology	1998	204
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. E. Berns, John A. Foekens, R. van Vossen, PubMed Breast OncologyPathologyComplete SequencingSystemic TherapyCancer Biology	2000	197

Page 1